• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星抑制人巨细胞病毒 UL97 激酶的正常功能。

Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.

机构信息

University of Alabama at Birmingham, Department of Pediatrics, 128 Children's Harbor Building, 1600 6th Avenue South, Birmingham, AL 35233-1711, USA.

出版信息

Antimicrob Agents Chemother. 2011 Oct;55(10):4682-91. doi: 10.1128/AAC.00571-11. Epub 2011 Jul 25.

DOI:10.1128/AAC.00571-11
PMID:21788463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3186952/
Abstract

Cyclopropavir (CPV) is active against human cytomegalovirus (CMV), as well as both variants of human herpesvirus 6 and human herpesvirus 8. The mechanism of action of CPV against CMV is similar to that of ganciclovir (GCV) in that it is phosphorylated initially by the CMV UL97 kinase, resulting in inhibition of viral DNA synthesis. Resistance to CPV maps to the UL97 kinase but is associated primarily with H520Q mutations and thus retains good antiviral activity against most GCV-resistant isolates. An examination of CMV-infected cultures treated with CPV revealed unusual cell morphology typically associated with the absence of UL97 kinase activity. A surrogate assay for UL97 kinase activity confirmed that CPV inhibited the activity of this enzyme and that its action was similar to the inhibition seen with maribavir (MBV) in this assay. Combination studies using real-time PCR indicated that, like MBV, CPV also antagonized the efficacy of GCV and were consistent with the observed inhibition of the UL97 kinase. Deep sequencing of CPV-resistant laboratory isolates identified a frameshift mutation in UL27, presumably to compensate for a loss of UL97 enzymatic activity. We conclude that the mechanism of action of CPV against CMV is complex and involves both the inhibition of DNA synthesis and the inhibition of the normal activity of the UL97 kinase.

摘要

环丙沙星(CPV)对人巨细胞病毒(CMV)以及人疱疹病毒 6 型和人疱疹病毒 8 型的两种变体均具有活性。CPV 对 CMV 的作用机制与更昔洛韦(GCV)相似,即最初被 CMV UL97 激酶磷酸化,从而抑制病毒 DNA 合成。CPV 耐药性与 UL97 激酶有关,但主要与 H520Q 突变相关,因此对大多数 GCV 耐药株仍具有良好的抗病毒活性。对 CPV 处理的 CMV 感染培养物的检查显示出异常的细胞形态,通常与 UL97 激酶活性缺失有关。对 UL97 激酶活性的替代测定证实 CPV 抑制了该酶的活性,其作用与该测定中 MBV 的抑制作用相似。使用实时 PCR 的联合研究表明,CPV 与 MBV 一样,也拮抗 GCV 的疗效,与观察到的 UL97 激酶抑制一致。对 CPV 耐药的实验室分离株进行深度测序发现 UL27 发生移码突变,可能是为了弥补 UL97 酶活性的丧失。我们得出结论,CPV 对 CMV 的作用机制复杂,涉及 DNA 合成的抑制和 UL97 激酶正常活性的抑制。

相似文献

1
Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.环丙沙星抑制人巨细胞病毒 UL97 激酶的正常功能。
Antimicrob Agents Chemother. 2011 Oct;55(10):4682-91. doi: 10.1128/AAC.00571-11. Epub 2011 Jul 25.
2
Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance.巨细胞病毒 UL97 激酶催化结构域突变导致多药耐药。
Antimicrob Agents Chemother. 2013 Jul;57(7):3375-9. doi: 10.1128/AAC.00511-13. Epub 2013 May 6.
3
Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir.更昔洛韦和马里巴韦时代的巨细胞病毒UL97突变
Rev Med Virol. 2008 Jul-Aug;18(4):233-46. doi: 10.1002/rmv.574.
4
Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.多种巨细胞病毒UL27突变可适应在马里巴韦作用下病毒UL97激酶活性的丧失。
Antimicrob Agents Chemother. 2009 Jan;53(1):81-5. doi: 10.1128/AAC.01177-08. Epub 2008 Nov 3.
5
Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.巨细胞病毒UL97激酶突变导致对马立巴韦耐药。
J Infect Dis. 2007 Jul 1;196(1):91-4. doi: 10.1086/518514. Epub 2007 May 17.
6
Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.人巨细胞病毒对环丙沙星的耐药性与 UL97 开放阅读框中的碱基对缺失有关。
Antimicrob Agents Chemother. 2013 Sep;57(9):4343-8. doi: 10.1128/AAC.00214-13. Epub 2013 Jul 1.
7
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.抗药性药物暴露后选择的巨细胞病毒 DNA 聚合酶突变体对环丙沙星的敏感性。
Antimicrob Agents Chemother. 2012 Jan;56(1):197-201. doi: 10.1128/AAC.05559-11. Epub 2011 Oct 3.
8
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.对更昔洛韦、西多福韦或膦甲酸钠耐药的巨细胞病毒分离株对马里巴韦的敏感性
J Clin Virol. 2006 Oct;37(2):124-7. doi: 10.1016/j.jcv.2006.07.010. Epub 2006 Sep 8.
9
Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.巨细胞病毒 UL97 突变影响丙氧鸟苷和更昔洛韦的敏感性。
Antimicrob Agents Chemother. 2011 Jan;55(1):382-4. doi: 10.1128/AAC.01259-10. Epub 2010 Nov 1.
10
Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo.体外和体内药物暴露后检测到的巨细胞病毒 UL97 激酶 ATP 结合区域突变对马拉韦罗敏感性的影响。
Antiviral Res. 2012 Aug;95(2):88-92. doi: 10.1016/j.antiviral.2012.05.013. Epub 2012 Jun 1.

引用本文的文献

1
In Silico Analysis of Mechanisms of Maribavir-Induced Inhibition and Drug Resistance Mutations in pUL97 Kinase Structural Prediction with AlphaFold2.利用AlphaFold2对马里巴韦诱导的pUL97激酶抑制机制和耐药性突变进行计算机模拟分析及结构预测
Viruses. 2025 Jul 2;17(7):941. doi: 10.3390/v17070941.
2
Anti-CMV therapy, what next? A systematic review.抗巨细胞病毒治疗,接下来该何去何从?一项系统综述。
Front Microbiol. 2023 Nov 20;14:1321116. doi: 10.3389/fmicb.2023.1321116. eCollection 2023.
3
Antiviral Drugs Against Herpesviruses.抗疱疹病毒药物。
Adv Exp Med Biol. 2021;1322:1-30. doi: 10.1007/978-981-16-0267-2_1.
4
Filociclovir Is an Active Antiviral Agent against Ocular Adenovirus Isolates In Vitro and in the Ad5/NZW Rabbit Ocular Model.泛昔洛韦是一种针对眼部腺病毒分离株的体外及Ad5/NZW兔眼部模型的活性抗病毒药物。
Pharmaceuticals (Basel). 2021 Mar 26;14(4):294. doi: 10.3390/ph14040294.
5
The Cytomegalovirus Protein Kinase pUL97:Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting.巨细胞病毒蛋白激酶pUL97:宿主相互作用、调控机制及抗病毒药物靶向作用
Microorganisms. 2020 Apr 4;8(4):515. doi: 10.3390/microorganisms8040515.
6
Advances in the Development of Therapeutics for Cytomegalovirus Infections.巨细胞病毒感染治疗方法的进展
J Infect Dis. 2020 Mar 5;221(Suppl 1):S32-S44. doi: 10.1093/infdis/jiz493.
7
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy.从更昔洛韦和膦甲酸钠转移:CMV 治疗的进展。
Curr Hematol Malig Rep. 2020 Apr;15(2):90-102. doi: 10.1007/s11899-020-00557-6.
8
Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance.巨细胞病毒抗病毒药物耐药性的基因诊断进展。
Antiviral Res. 2020 Apr;176:104711. doi: 10.1016/j.antiviral.2020.104711. Epub 2020 Jan 12.
9
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.评估健康志愿者中多次递增剂量膦甲酸钠(MBX-400,环丙氧鸟苷)的安全性和药代动力学的 Ib 期临床试验。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00717-19. Print 2019 Sep.
10
Novel Therapeutics for Epstein⁻Barr Virus.新型治疗 Epstein⁻Barr 病毒的方法。
Molecules. 2019 Mar 12;24(5):997. doi: 10.3390/molecules24050997.

本文引用的文献

1
CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections.CMX001 增强阿昔洛韦在单纯疱疹病毒感染中的疗效。
Antimicrob Agents Chemother. 2011 Oct;55(10):4728-34. doi: 10.1128/AAC.00545-11. Epub 2011 Jul 25.
2
Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.靶向 HCMV 激酶 pUL97 的抗病毒抑制作用需要 pUL27 依赖性降解 Tip60 乙酰转移酶和细胞周期停滞。
Cell Host Microbe. 2011 Feb 17;9(2):103-14. doi: 10.1016/j.chom.2011.01.006.
3
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.奥司他韦-扎那米韦联合治疗与每种单药治疗季节性流感的疗效比较:一项随机安慰剂对照试验。
PLoS Med. 2010 Nov 2;7(11):e1000362. doi: 10.1371/journal.pmed.1000362.
4
Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility.巨细胞病毒 UL97 突变影响丙氧鸟苷和更昔洛韦的敏感性。
Antimicrob Agents Chemother. 2011 Jan;55(1):382-4. doi: 10.1128/AAC.01259-10. Epub 2010 Nov 1.
5
Antiviral drug resistance of human cytomegalovirus.人巨细胞病毒的抗病毒药物耐药性。
Clin Microbiol Rev. 2010 Oct;23(4):689-712. doi: 10.1128/CMR.00009-10.
6
Phosphorylation of antiviral and endogenous nucleotides to di- and triphosphates by guanosine monophosphate kinase.鸟苷一磷酸激酶将抗病毒和内源性核苷酸磷酸化为二磷酸和三磷酸。
Biochem Pharmacol. 2011 Jan 1;81(1):43-9. doi: 10.1016/j.bcp.2010.09.005. Epub 2010 Sep 22.
7
Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir.pUL97 对环丙沙星的立体选择性磷酸化作用和马拉韦罗的竞争性抑制作用。
Antimicrob Agents Chemother. 2010 Aug;54(8):3093-8. doi: 10.1128/AAC.00468-10. Epub 2010 Jun 14.
8
Synthesis and enantioselectivity of cyclopropavir phosphates for cellular GMP kinase.用于细胞GMP激酶的环丙沙星磷酸盐的合成及对映选择性
Nucleosides Nucleotides Nucleic Acids. 2009 Sep;28(9):795-808. doi: 10.1080/15257770903172720.
9
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.金刚烷胺、利巴韦林和奥司他韦三联用药对体外耐药流感病毒株具有高度活性和协同作用。
PLoS One. 2010 Feb 22;5(2):e9332. doi: 10.1371/journal.pone.0009332.
10
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.5-取代的 4'-硫代嘧啶核苷抑制疱疹病毒复制。
Antimicrob Agents Chemother. 2009 Dec;53(12):5251-8. doi: 10.1128/AAC.00417-09. Epub 2009 Sep 21.